ALKERAN A2A (Alkeran 2 mg)
Generic Name: melphalan
Pill imprint ALKERAN A2A has been identified as Alkeran 2 mg.
Alkeran is used in the treatment of multiple myeloma; ovarian cancer and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Alkeran 2 mg is not a controlled substance under the Controlled Substance Act (CSA).
Alkeran
- Generic Name:
- melphalan
- Imprint:
- ALKERAN A2A
- Strength:
- 2 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Alkylating agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Apo Pharma USA
More about Alkeran (melphalan)
Consumer resources
- Alkeran
- Alkeran tablets
- Alkeran I.V. oral/injection
- Alkeran oral/injection
- Alkeran (Advanced Reading)
- Alkeran IV (Advanced Reading)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
